Corporate strategy
What belongs in the pipeline, in what order, and what an asset is worth. Prioritization, valuation, and planning.

Work
What belongs in the pipeline, in what order, and what an asset is worth. Prioritization, valuation, and planning.
Who to call, what the deal should look like, and staying through diligence and terms.

Principal
Founder · U.S. Army veteran
Over 24 years in pharma and biotech. Portfolio strategy, valuation, and business development across pipeline and commercial assets, including more than $900 million in partnerships.
Ph.D. in biophysics, Brandeis. Postdoc, MIT. M.S. Finance, William & Mary. Retired U.S. Army Reserve lieutenant colonel.
Contact